IMPORTANT: 6CPA PROGRAM CHANGES FROM 1 JULY 2017


From 1 July there will be changes in line with the recent agreement with Government to fund community pharmacies to support and improve Australians’ access to medicines, under the Improving Access to Medicines – support for community pharmacies measure. This includes $600 million through the Sixth Community Pharmacy Agreement (6CPA) to continue existing community pharmacy programs and enable pharmacists to deliver new and expanded medication management services for Australians who need additional assistance to manage their medications.

The following programs have been redesigned to support the collection of information to assist with the assessment of the effectiveness of these services:

Dose Administration Aids

The current Pharmacy Practice Incentive payment for Dose Administration Aids (DAAs) will end on 30 June 2017, however claims for DAAs provided in June may be submitted between 1 July and 14 July 2017.

From 1 July 2017, community pharmacies participating in the DAA program will receive a fee of $6 per patient per week as a contribution towards the cost of providing the service to patients that meet the eligibility criteria.

6CPA Dose Administration Aids (DAA) Program Rules - 1 July 2017 (pdf - 269 KB)

 

Staged Supply

The current Pharmacy Practice Incentive payment of $1,300 per annum for Staged Supply (SS) will end on 30 June 2017.

From 1 July 2017, community pharmacies participating in the SS program will receive a new weekly fee-for-service per patient for up to four eligible patients per pharmacy. In addition, to support the collection of information and monitor the SS program’s delivery of health outcomes for patients, community pharmacies will be required to collect data for the patients funded under this service.

6CPA Staged Supply Program Rules - 1 July 2017 (pdf - 263 KB)

 

MedsCheck & Diabetes MedsCheck

From 1 July 2017, the number of MedsCheck and Diabetes MedsChecks that can be conducted and claimed by community pharmacies will be increased from a total of ten per calendar month to a total of 20 per calendar month.

6CPA MedsCheck and Diabetes MedsCheck Program Rules - 1 July 2017 (pdf - 271 KB)

 

Home Medicines Review Program

The Home Medicines Review (HMR) Program will continue unchanged from 1 July 2017 while a review of the current MBS item 900 eligibility criteria is undertaken. Potential changes to patient eligibility criteria, the inclusion of two new in-pharmacy follow-up services, and criteria to increase access to the service for Aboriginal and Torres Strait Islander patients are anticipated to commence in early 2018.

6CPA Home Medicine Review (HMR) Program Rules - 1 July 2017 (pdf - 245 KB)